FdaApplication

ANDA 091224

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2019-07-19

Products (6)

ProductActive ingredientStrengthDosage form
PREGABALINPREGABALIN200MGCAPSULE;ORAL
PREGABALINPREGABALIN75MGCAPSULE;ORAL
PREGABALINPREGABALIN150MGCAPSULE;ORAL
PREGABALINPREGABALIN225MGCAPSULE;ORAL
PREGABALINPREGABALIN100MGCAPSULE;ORAL
PREGABALINPREGABALIN300MGCAPSULE;ORAL

6 products